East Genomics

Mobile menu open

Generation Study

The East GMSA will be collaborating with Genomics England in delivering the ‘Generation Study’, formerly known as the Newborn Genomes Programme.

This project will evaluate the potential of identifying actionable childhood-onset rare genetic conditions following birth, by sequencing and analysing 100,000 babies’ genomes.

This could contribute to improved outcomes and quality of life for babies and families.

Newborn baby and mother

Aims of the Generation Study

The Generation Study has three main aims:

  1. To evaluate the utility and feasibility of screening newborns for several childhood onset rare genetic conditions using genomic technologies.
  2. To understand how genomic data could improve knowledge and treatments.
  3. To explore potential risks and benefits of storing an individual’s genome over their lifetime.

See also Genomics England's Generation Study Vision document (opens in a new tab).

Who are we working with?

This is a national study being led by Genomics England (opens in a new tab). You can find out more about the Generation Study on their website:

A full list of NHS Trust pilot sites will be released shortly, and updated here.

Progress so far

July 2023

We held a dedicated education and training session as part of our Genomics BITEs series. The session was delivered by Sally Shillaker, Clinical Content Developer at Genomics England. You can watch the recording below.

October 2023

Recording of an NHS East Genomics session on the Generation Study, delivered by Sally Shillaker from Genomics England in July 2023

Link: https://www.youtube.com/watch?v=taXx4q9urqs&list=PLQfvULnuzrf0Q191TcfKKyyH8ns1_0wjw&index=5

Meet the East GMSA team